Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$73.77 - $83.61 $1.81 Million - $2.05 Million
-24,474 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$76.38 - $86.03 $1.67 Million - $1.89 Million
-21,912 Reduced 47.24%
24,474 $2.06 Million
Q4 2020

Jan 28, 2021

SELL
$75.39 - $82.36 $75,390 - $82,360
-1,000 Reduced 2.11%
46,386 $3.72 Million
Q3 2020

Nov 03, 2020

BUY
$78.33 - $90.73 $686,562 - $795,248
8,765 Added 22.69%
47,386 $3.81 Million
Q2 2020

Aug 04, 2020

BUY
$78.66 - $94.14 $157 - $188
2 Added 0.01%
38,621 $3.33 Million
Q1 2020

May 07, 2020

SELL
$71.57 - $93.3 $709,473 - $924,882
-9,913 Reduced 20.43%
38,619 $3.14 Million
Q4 2019

Jan 21, 2020

SELL
$76.7 - $88.45 $47,937 - $55,281
-625 Reduced 1.27%
48,532 $4.06 Million
Q3 2019

Oct 11, 2019

SELL
$81.4 - $89.78 $1.55 Million - $1.71 Million
-19,075 Reduced 27.96%
49,157 $4.3 Million
Q2 2019

Jul 24, 2019

SELL
$73.44 - $82.41 $111,996 - $125,675
-1,525 Reduced 2.19%
68,232 $5.59 Million
Q1 2019

Apr 23, 2019

BUY
$64.48 - $81.31 $322 - $406
5 Added 0.01%
69,757 $5.67 Million
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $800,386 - $1.01 Million
13,025 Added 22.96%
69,752 $4.59 Million
Q3 2018

Nov 02, 2018

SELL
$70.71 - $77.75 $998,778 - $1.1 Million
-14,125 Reduced 19.94%
56,727 $4.37 Million
Q2 2018

Aug 01, 2018

SELL
$63.43 - $75.41 $26,957 - $32,049
-425 Reduced 0.6%
70,852 $5.23 Million
Q1 2018

May 01, 2018

SELL
$62.56 - $72.26 $132,126 - $152,613
-2,112 Reduced 2.88%
71,277 $4.64 Million
Q4 2017

Feb 06, 2018

SELL
$61.45 - $66.05 $707,473 - $760,433
-11,513 Reduced 13.56%
73,389 $4.74 Million
Q3 2017

Oct 31, 2017

BUY
$59.5 - $64.61 $5.05 Million - $5.49 Million
84,902
84,902 $5.33 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Decatur Capital Management, Inc. Portfolio

Follow Decatur Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Decatur Capital Management, Inc. with notifications on news.